Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Valziflocept - Takeda

Next Previous
Drug Profile

Valziflocept - Takeda

Alternative Names: BAX 1810; FcγRIIb; Human soluble Fc-gamma receptor IIb - Takeda; OHB-101; SHP 652; SM-101; TAK-752

Latest Information Update: 04 Aug 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SuppreMol
  • Developer Baxalta; Oak Hill Bio; Takeda
  • Class Immunoglobulin Fc fragments; Recombinant proteins
  • Mechanism of Action Fc gamma receptor IIB modulators; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Idiopathic thrombocytopenic purpura
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Idiopathic thrombocytopenic purpura; IgA nephropathy
  • Discontinued Chronic obstructive pulmonary disease; Systemic lupus erythematosus

Most Recent Events

  • 04 Aug 2022 Oak Hill Bio plans a phase IIb trial in Systemic Lupus Erythematosus (Oak Hill Bio pipeline, August 2022)
  • 01 Feb 2022 Phase-II development is ongoing for IgA nephropathy and Idiopathic thrombocytopenic purpura (Oak Hill Bio Pipeline, February 2022)
  • 01 Feb 2022 Valziflocept licensed to Oak Hill Bio worldwide

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top